Answers are grounded in this paper and cite their sources.
Evaluation shows OSTA and FRAX detect osteoporosis in type 2 diabetes patients, indicating FRAX may offer better predictive performance.
Objective: We investigated the accuracy of OSTA and FRAX screening tools (without BMD measurements) in identifying osteoporosis among Type 2 diabetes patients. Methodology: This study was performed at the Department of Diabetes and Endocrinology, Lady Reading Hospital Peshawar, and included 174 T2DM patients aged 45-65 of either sex who had “Dual-Energy X-ray absorptiometry” (DEXA) scan. Results: Osteoporosis was detected in 28.6% of lumbar spine measurements and 22.3% of femoral neck measurements. Researchers identified a strong negative correlation between bone mineral density (BMD) and FRAX score for both “Major Osteoporotic Fractures” (MOF) and “Hip Fractures” (HF) at both skeletal sites examined (p < 0.001). The OSTA score demonstrated a positive correlation with BMD at both the lumbar spine (p = 0.002) and femoral neck (p < 0.001). When assessing predictive performance, area under the curve (AUC) values were 0.83 (95% CI, 0.7-0.9) for FRAX-MOF, 0.87 (95% CI, 0.8-0.9) for FRAX-HF, and 0.61 (95% CI, 0.5-0.7) for OSTA. Conclusion: Both OSTA and FRAX effectively detect primary osteoporosis, with FRAX showing slightly superior performance in type 2 diabetes patients. These tools help identify high-risk T2DM patients and provide practical solutions for appropriately using DEXA scans, especially in areas without DEXA availability
No takes yet. Share an insight, caveat, or question.
Ullah et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: